P-253A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) refractory to standard chemotherapy: APOLLON study. (20th June 2018) - Yamazaki, K; Yasui, H; Yamaguchi, K; Kagawa, Y; Kuboki, Y; Yoshino, T; Gamoh, M; Komatsu, Y; Satake, H; Goto, M; Tanioka, H; Oki, E; et al.